Cardiology Medical News about Factor VII Factor VII Deficiency

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: Where should we go from here
Pediatric Critical Care, 09/18/09

Warren OJ et al. – rFVIIa has an increasingly accepted role in the management of patients with congenital coagulopathies undergoing major surgery. However, randomized trials are required to define the role of rFVIIa as an adjunct to control major hemorrhage in the pediatric cardiac surgical population. Any future work must focus not only on benefits but also on patient safety, particularly, risk of morbid thromboembolic complication.

<< Previous
Study of ACEI versus ARB in Managing Hypertensive Overt Diabetic...

Next >>
HDL3-Mediated Inactivation of LDL-Associated Phospholipid...